Traceless Reductive Linkers for Acid-Stable Peptide Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for purifying peptides using solid phase peptide synthesis (SPPS) face challenges such as high costs, scalability issues, solvent consumption, and unwanted side reactions due to the instability of linker molecules under acidic or basic conditions, particularly affecting peptides with specific amino acids like cysteine, methionine, and arginine.
Innovation Solution
Development of linker molecules that are stable under TFA conditions and allow peptide release under mild acidic conditions (pH≤7), using moieties like amine switches with azide reductive safety locks, nucleophilic releases, or carbamate switches to minimize side reactions and enhance stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional linker molecules are used for peptide purification, then peptide release can be achieved under basic conditions, but the linker becomes unstable under acidic TFA conditions leading to premature decay and side reactions
Solution Approach 1:
The patent changes the chemical parameters of the linker molecule by introducing electron-withdrawing groups (such as fluorine, chlorine, bromine, iodine, or trifluoromethyl groups) at specific positions (ortho or para to the carbamate oxygen, or meta to the benzylic carbon). This parameter change modifies the electronic properties of the linker to enhance its stability under acidic TFA conditions while maintaining controlled lability under basic conditions for peptide release.
Solution Approach 2:
The patent creates a composite linker structure combining multiple functional elements: a benzylic carbonate or carbamate core, electron-withdrawing aromatic substituents, and a peptide-cleavable linker portion. This composite structure integrates the stability-providing electron-withdrawing groups with the peptide-release functionality, achieving both acid stability and base-triggered cleavage.
2Manufacturing precision
If HPLC purification method is used, then peptide purification can be achieved, but the method has poor scalability and high acquisition costs
Solution Approach 1:
The patent extracts the purification function from the complex HPLC system and integrates it into the peptide synthesis process itself through the use of solid-phase purification resins. The linker molecule enables direct purification on the synthesis bead, eliminating the need for separate HPLC equipment and procedures, thereby improving scalability while maintaining purification quality.
Solution Approach 2:
The patent implements a self-service purification approach where the linker molecule itself facilitates the purification process. The peptide remains attached to the synthesis resin through the linker during synthesis, and purification is achieved by washing the resin-bound intermediate, eliminating the need for external purification equipment and complex analytical assessment procedures.
3Strength
If thiol-containing linker molecules are used for purification, then covalent binding to support can be achieved, but the method is not suitable for peptides containing cysteine or penicillamine
Solution Approach 1:
The patent uses an aromatic carbamate or carbonate intermediate structure that mediates between the solid support and the peptide. This intermediary linker provides stable covalent binding to the support through the aromatic core while presenting a non-thiol reactive interface to the peptide, avoiding direct thiol-peptide interactions that would limit compatibility with cysteine-containing peptides.
Solution Approach 2:
The patent extracts the thiol functionality from the linker molecule and replaces it with electron-withdrawing aromatic groups that provide equivalent or superior binding strength through different chemical mechanisms (such as covalent attachment to solid support via the aromatic core). This removal of thiol groups eliminates the incompatibility with cysteine-containing peptides while maintaining strong binding capabilities.
4Productivity
If basic conditions are used for peptide release, then cleavage can be achieved, but unwanted side reactions occur with peptides containing Thr, Ser, or Cys at N-terminus
Solution Approach 1:
The patent changes the pH parameter conditions for peptide release by designing the linker to be stable at basic pH values (pH 8-10) used during synthesis and purification, but labile under mild acidic conditions (pH 2-4). This parameter inversion allows peptide release without exposing basic side chains (Thr, Ser, Cys) to nucleophilic attack conditions, eliminating side reactions while maintaining cleavage efficiency.
Solution Approach 2:
The patent inverts the traditional approach by making the linker stable under basic conditions (used during synthesis) and labile under acidic conditions (used for release). This inversion of stability conditions prevents nucleophilic side reactions at basic pH while enabling efficient peptide cleavage at acidic pH, solving the compatibility issue with peptides containing nucleophilic side chains.
Data Source
AI summary
The present invention relates to linker molecules of formula (1), X-Tb-Va—U—Y—Z (1) and a method for purifying peptides using said linker molecules. The linker molecule can be coupled to a purification resin via the moiety X and to a peptide via the moiety Y under the release of the leaving group Z. T is an optional spacer moiety and V is an optional electron withdrawing moiety. U is an aryl or 5- or 6-membered heteroaryl moiety bound to at least one electron withdrawing moiety V, W or E. The linker is stable under acidic conditions and releases the peptide upon addition of a reducing agent.